98 related articles for article (PubMed ID: 18509187)
1. Fatal toxic epidermal necrolysis associated with cetuximab in a patient with colon cancer.
Lin WL; Lin WC; Yang JY; Chang YC; Ho HC; Yang LC; Yang CH; Hung SI; Chung WH
J Clin Oncol; 2008 Jun; 26(16):2779-80. PubMed ID: 18509187
[No Abstract] [Full Text] [Related]
2. Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma.
Krishnan G; D'Silva K; Al-Janadi A
J Clin Oncol; 2008 May; 26(14):2406-8. PubMed ID: 18467734
[No Abstract] [Full Text] [Related]
3. Toxic epidermal necrolysis caused by cetuximab plus minocycline in head and neck cancer.
Lee SS; Chu PY
Am J Otolaryngol; 2010; 31(4):288-90. PubMed ID: 20015761
[TBL] [Abstract][Full Text] [Related]
4. Papulo-pustular eruption during cetuximab treatment.
Satta R; Cuccuru MA; Pirodda C; Cottoni F
G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
[No Abstract] [Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer.
Urosevic-Maiwald M; Harr T; French LE; Dummer R
Int J Dermatol; 2012 Jul; 51(7):864-7. PubMed ID: 22715836
[TBL] [Abstract][Full Text] [Related]
6. Cetuximab-associated folliculitis predominantly affecting the lower limbs.
Oberholzer PA; Borradori L; Beltraminelli H
J Dtsch Dermatol Ges; 2011 Sep; 9(9):703-4. PubMed ID: 21627774
[No Abstract] [Full Text] [Related]
7. [Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab].
Coquart N; Karam A; Metges JP; Misery L
Ann Dermatol Venereol; 2010 Apr; 137(4):306-7. PubMed ID: 20417368
[No Abstract] [Full Text] [Related]
8. Trichomegaly of the eyelashes following treatment with cetuximab.
Vaccaro M; Pollicino A; Barbuzza O; Guarneri B
Clin Exp Dermatol; 2009 Apr; 34(3):402-3. PubMed ID: 19120397
[No Abstract] [Full Text] [Related]
9. Behavioral disorders secondary to profound hypomagnesemia in a patient given cetuximab for metastatic colorectal cancer hypomagnesemia due to cetuximab treatment.
Perrin C; Fabre C; Raoul JL; Boucher E
Acta Oncol; 2006; 45(8):1135-6. PubMed ID: 17118852
[No Abstract] [Full Text] [Related]
10. Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.
Fang B; Song Y; Ma J; Zhao RC
Acta Haematol; 2007; 118(2):65-7. PubMed ID: 17505132
[No Abstract] [Full Text] [Related]
11. Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus.
Jongen-Lavrencic M; Schneeberger PM; van der Hoeven JG
Infection; 2003 Dec; 31(6):428-9. PubMed ID: 14735388
[TBL] [Abstract][Full Text] [Related]
12. Management of toxic epidermal necrolysis.
Pirrung MK
J Intraven Nurs; 2001; 24(2):107-12. PubMed ID: 11836835
[TBL] [Abstract][Full Text] [Related]
13. CALGB/SWOG C80405: A phase III trial of FOLFIRI or FOLFOX with bevacizumab or cetuximab or both for untreated metastatic adenocarcinoma of the colon or rectum.
Clin Adv Hematol Oncol; 2006 Jun; 4(6):452-3. PubMed ID: 16981668
[No Abstract] [Full Text] [Related]
14. Toxic epidermal necrolysis induced by levofloxacin.
Davila G; Ruiz-Hornillos J; Rojas P; De Castro F; Zubeldia JM
Ann Allergy Asthma Immunol; 2009 May; 102(5):441-2. PubMed ID: 19492670
[No Abstract] [Full Text] [Related]
15. Neutrophilic eccrine hidradenitis induced by cetuximab.
Turan H; Kaya E; Gurlevik Z; Erdem H; Oktay M
Cutan Ocul Toxicol; 2012 Jun; 31(2):148-50. PubMed ID: 22034841
[TBL] [Abstract][Full Text] [Related]
16. Ocular toxicity related to cetuximab monotherapy in an advanced colorectal cancer patient.
Tonini G; Vincenzi B; Santini D; Olzi D; Lambiase A; Bonini S
J Natl Cancer Inst; 2005 Apr; 97(8):606-7. PubMed ID: 15840884
[No Abstract] [Full Text] [Related]
17. Toxic epidermal necrolysis-like reaction secondary to colchicine overdose.
Arroyo MP; Sanders S; Yee H; Schwartz D; Kamino H; Strober BE
Br J Dermatol; 2004 Mar; 150(3):581-8. PubMed ID: 15030347
[TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption.
Eiling E; Brandt M; Schwarz T; Hauschild A
Arch Dermatol; 2008 Sep; 144(9):1236-8. PubMed ID: 18794482
[No Abstract] [Full Text] [Related]
19. Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.
Montagut C; Grau JJ; Grimalt R; Codony J; Ferrando J; Albanell J
J Clin Oncol; 2005 Aug; 23(22):5273-5. PubMed ID: 16051981
[No Abstract] [Full Text] [Related]
20. Fatal pristinamycin-induced toxic epidermal necrolysis (Lyell's syndrome): difficulties in attributing causal association in the polymedicated intensive care unit patient.
Chanques G; Girard C; Pinzani V; Jaber S
Acta Anaesthesiol Scand; 2005 May; 49(5):721-2. PubMed ID: 15836693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
